OFLOXACIN
CHLAMYDIA TRACHOMATIS URETHRITIS·+27
DR.REDDY'S LAB
Indication
Pseudomonas aeruginosa cystitis
*Pseudomonas aeruginosa* cystitis is a lower urinary tract infection characterized by bacterial inflammation of the urinary bladder caused by the opportunistic Gram-negative rod *Pseudomonas aeruginosa*. Read more about Pseudomonas aeruginosa cystitis
2 drugs 2 manufacturers
Drugs that treat it
Common Pseudomonas aeruginosa cystitis therapies.
OFLOXACIN
QUINOLONES·CHLAMYDIA TRACHOMATIS URETHRITIS·+27
MODAVAR PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Pseudomonas aeruginosa cystitis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Pseudomonas aeruginosa* cystitis is a lower urinary tract infection characterized by bacterial inflammation of the urinary bladder caused by the opportunistic Gram-negative rod *Pseudomonas aeruginosa*.
It primarily occurs as a complicated or healthcare-associated infection, disproportionately affecting individuals with indwelling urinary catheters, structural or functional urinary tract abnormalities, recent urologic instrumentation, or broad-spectrum antimicrobial exposure.
Clinically, patients present with symptoms such as dysuria, urinary frequency, urgency, and suprapubic discomfort, accompanied by pyuria and bacteriuria.
Pathophysiologically, the condition is driven by the organism's specialized virulence traits—notably robust biofilm formation on urothelial and device surfaces—alongside high rates of intrinsic and acquired multidrug resistance.
- nih.gov
*Pseudomonas aeruginosa* cystitis is a lower urinary tract infection characterized by bacterial inflammation of the urinary bladder caused by the opportunistic Gram-negative rod *Pseudomonas aeruginosa*
- nih.gov
It primarily occurs as a complicated or healthcare-associated infection, disproportionately affecting individuals with indwelling urinary catheters, structural or functional urinary tract abnormalities, recent urologic instrumentation, or broad-spectrum antimicrobial exposure Pathophysiologically, the condition is driven by the organism's specialized virulence traits—notably robust biofilm formation on urothelial and device surfaces—alongside high rates of intrinsic and acquired multidrug resist...
- nih.gov
It primarily occurs as a complicated or healthcare-associated infection, disproportionately affecting individuals with indwelling urinary catheters, structural or functional urinary tract abnormalities, recent urologic instrumentation, or broad-spectrum antimicrobial exposure
- urotoday.com
It primarily occurs as a complicated or healthcare-associated infection, disproportionately affecting individuals with indwelling urinary catheters, structural or functional urinary tract abnormalities, recent urologic instrumentation, or broad-spectrum antimicrobial exposure
- nih.gov
Clinically, patients present with symptoms such as dysuria, urinary frequency, urgency, and suprapubic discomfort, accompanied by pyuria and bacteriuria
- nih.gov
Clinically, patients present with symptoms such as dysuria, urinary frequency, urgency, and suprapubic discomfort, accompanied by pyuria and bacteriuria
- nih.gov
Pathophysiologically, the condition is driven by the organism's specialized virulence traits—notably robust biofilm formation on urothelial and device surfaces—alongside high rates of intrinsic and acquired multidrug resistance
- cdc.gov
Pathophysiologically, the condition is driven by the organism's specialized virulence traits—notably robust biofilm formation on urothelial and device surfaces—alongside high rates of intrinsic and acquired multidrug resistance
Personalize your experience
Follow Pseudomonas aeruginosa cystitis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.